Inventor · disambiguated record
Erik James Hembre
Also filed as: HEMBRE ERIK J · HEMBRE ERIK JAMES · HEMBRE II ERIK JAMES
19 granted patents·3 pending applications·167 citations·filing 1997–2021
93Inventor score
Files withLILLY CO ELI14ARNOLD MACKLIN BRIAN3UNIV MICHIGAN3AMEGADZIE ALBERT K1AMEGADZIE ALBERT KUDZOVI1
Top patents by PatentIndex Score
22 records- 0193US8030304B2Thiazole pyrazolopyrimidines CRF1 receptor antagonistsLILLY CO ELI·Filed 2007·Granted Oct 4, 2011·35 cites·10 claims
- 0292US9522923B2Selective BACE1 inhibitorsLILLY CO ELI·Filed 2016·Granted Dec 20, 2016·22 cites·17 claims
- 0391US7612067B2Imidazopyridazine compoundsLILLY CO ELI·Filed 2006·Granted Nov 3, 2009·36 cites·10 claims
- 0486US7179804B2Tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Feb 20, 2007·30 cites·18 claims
- 0585US7320994B2Triazole derivatives as tachykinin receptor antagonistsLILLY CO ELI·Filed 2003·Granted Jan 22, 2008·28 cites·34 claims
- 0680US7902356B2Thiazolopyridinone derivates as MCH receptor antagonistsLILLY CO ELI·Filed 2005·Granted Mar 8, 2011·6 cites·11 claims
- 0770US8263772B2MCH receptor antagonistsARNOLD MACKLIN BRIAN·Filed 2007·Granted Sep 11, 2012·2 cites·2 claims
- 0866US10227310B2Ghrelin 0-acyl transferase inhibitorsLILLY CO ELI·Filed 2016·Granted Mar 12, 2019·1 cites·20 claims
- 0966US10093651B2Ghrelin O-acyl transferase inhibitorsLILLY CO ELI·Filed 2016·Granted Oct 9, 2018·1 cites·17 claims
- 1064US9029367B2BACE inhibitorsLILLY CO ELI·Filed 2014·Granted May 12, 2015·0 cites·15 claims
- 1155US10399995B21,4-Oxazines useful as selective BACE1 inhibitorsLILLY CO ELI·Filed 2017·Granted Sep 3, 2019·0 cites·10 claims
- 1254US9169271B2BACE inhibitorsLILLY CO ELI·Filed 2015·Granted Oct 27, 2015·0 cites·14 claims
- 1353US12503442B2Phenyl-3,4-dihydroisoquinolin-2(1h)-yl-ethan-1-one derivatives as dopamine d1receptor positive allosteric modulatorsLILLY CO ELI·Filed 2021·Granted Dec 23, 2025·0 cites·14 claims
- 1446US8049013B25- [4-(azetidin-3-yloxy)-phenyl]-2-phenyl-5H-thiazolo[5,4-C] pyridin-4-one derivatives and their use as MCH receptor antagonistsLILLY CO ELI·Filed 2007·Granted Nov 1, 2011·0 cites·16 claims
- 1546US2019106434A1N-[3-[2-amino-5-(1,1-difluoroethyl)-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]oxazin-7a-yl]-4-fluoro-phenyl-5-(trifluoromethyl)pyridine-2-carboxamide and its (4ar,5s,7as) isomer as a selective bace1 inhibitor for treating e.g. alzheimer's diseaseLILLY CO ELI·Filed 2017·Application pending·0 cites
- 1644US2006160794A1Tachykinin receptor antagonistsAMEGADZIE ALBERT K·Filed 2004·Application pending·0 cites
- 1742US2012302547A1Novel mch receptor antagonistsARNOLD MACKLIN BRIAN·Filed 2012·Application pending·0 cites
- 1841US5919952AMethod for preparing swainsonineUNIV MICHIGAN·Filed 1997·Granted Jul 6, 1999·2 cites·14 claims
- 1937US8101764B2MCH receptor antagonistsAMEGADZIE ALBERT KUDZOVI·Filed 2007·Granted Jan 24, 2012·0 cites·14 claims
- 2037US6262065B1Swainsonine derivatives and methods for preparing the sameUNIV MICHIGAN·Filed 1998·Granted Jul 17, 2001·4 cites·11 claims
- 2135US8299061B2Inhibitors of diacylglycerol acyltransferaseARNOLD MACKLIN BRIAN·Filed 2010·Granted Oct 30, 2012·0 cites·16 claims
- 2223US6630484B16-and 7-substituted analogs of swainsonine their preparation and therapeutic useUNIV MICHIGAN·Filed 1997·Granted Oct 7, 2003·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Erik James Hembre files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →